NO.1 PHARMACY released its first-quarter performance, with a net profit attributable to the parent company of 4.7391 million yuan, a year-on-year decrease of 86.86%
NO.1 PHARMACY released its Q1 2025 performance report, with operating revenue of 504 million yuan, a year-on-year increase of 9.07%. However, the net profit attributable to shareholders of the listed company was 4.7391 million yuan, a year-on-year decrease of 86.86%. The net profit after deducting non-recurring gains and losses was 4.4955 million yuan, a year-on-year increase of 1.13%. The basic earnings per share were 0.0212 yuan/share
According to the Zhitong Finance APP, NO.1 PHARMACY (600833.SH) released its first-quarter report for 2025. The company's first-quarter operating revenue was 504 million yuan, a year-on-year increase of 9.07%; the net profit attributable to shareholders of the listed company was 4.7391 million yuan, a year-on-year decrease of 86.86%; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 4.4955 million yuan, a year-on-year increase of 1.13%; basic earnings per share were 0.0212 yuan/share
